Selective cardiac surveillance in patients with gynecologic cancer undergoing treatment with pegylated liposomal doxorubicin (PLD)

C. L. Kushnir, A. M. Angarita, L. J. Havrilesky, S. Thompson, D. Spahlinger, A. K. Sinno, E. J. Tanner, A. A. Secord, K. L. Roche, R. L. Stone, A. N. Fader*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Selective cardiac surveillance in patients with gynecologic cancer undergoing treatment with pegylated liposomal doxorubicin (PLD)'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science